LY-3009120
| CAS No. | 1454682-72-4 | Cat. No. | BCP23869 |
| Name | LY-3009120 | ||
| Synonyms | LY3009120; LY 3009120; DP4978; DP 4978; DP-4978; | ||
| Formula | C23H29FN6O | M. Wt | 424.51 |
| Description | LY3009120, also known as DP-4978, is potent and selective pan-RAF inhibitor with potential anticancer activity. LY3009120 showed activities against BRaf or Ras mutant tumor cells . LY3009120 binds to ARaf, BRaf and CRaf isoforms with similar affinity in cells with activating mutations of BRaf or KRas. LY3009120 induces minimal paradoxical pathway activation in NRas or KRas mutant cells. LY3009120 inhibits MEK phosphorylation and cell proliferation in vitro, and exhibits anti-tumor activity in multiple xenograft models carrying mutations in BRaf, NRas or KRas. | ||
| Pathways | MAPK Pathway | ||
| Targets | Raf | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.